Polomar Health Services (PMHS) Non-Current Assets (2023 - 2026)
Polomar Health Services (PMHS) posted Non-Current Assets of $33476.0 for Q2 2026, down 31.61% on a QoQ basis from $48950.0 in Q1 2026, and down 99.64% year-over-year from $9.3 million in Q2 2025.
Analysis
Polomar Health Services (PMHS) Non-Current Assets (2023 - 2026) Analysis & Trends
Polomar Health Services has reported Non-Current Assets for 4 years, with the latest figure at $33476.0 in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 99.64% year-over-year to $33476.0 in Q2 2026; TTM through Jun 2026 was $9.2 million, a 76.33% decrease from a year earlier, with the FY2025 full-year figure at $67316.0, down 99.32% from the prior year.
- Non-Current Assets was $33476.0 for Q2 2026 at Polomar Health Services, down from $48950.0 in the prior quarter.
- The five-year high for Non-Current Assets was $10.1 million in Q3 2024, with the low at $33476.0 in Q2 2026.
- Average Non-Current Assets over 4 years is $5.4 million, with a median of $9.1 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets jumped 10313.11% in 2024, then tumbled 99.64% in 2026.
- Over 4 years, Non-Current Assets stood at $94832.0 in 2023, then surged by 10313.11% to $9.9 million in 2024, then sank by 99.32% to $67316.0 in 2025, then slumped by 50.27% to $33476.0 in 2026.
- The last three Non-Current Assets figures came in at $33476.0 (Q2 2026), $48950.0 (Q1 2026), and $67316.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 26.10 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 24.99 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 2.92 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.83 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 18.27 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.04 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 668.68 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.11 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 3.25 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 33,476.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33,476.00 |
| Mar 31, 2026 | 48,950.00 |
| Dec 31, 2025 | 67,316.00 |
| Sep 30, 2025 | 9.07 Mn |
| Jun 30, 2025 | 9.34 Mn |
| Mar 31, 2025 | 9.61 Mn |
| Dec 31, 2024 | 9.87 Mn |
| Sep 30, 2024 | 10.14 Mn |
| Dec 31, 2023 | 94,832.00 |